Regulation of neurotransmitter release kinetics by NSF

Science

Volumn 279, Issue 5354, 1998, Pages 1203-1206

  Schweizer, Felix E ^a,b   Dresbach, Thomas ^c   DeBello, William M ^a,b   O'Connor, Vincent ^c   Augustine, George J ^a,b   Betz, Heinrich ^c  

^a DUKE UNIVERSITY   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

^c MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BINDING PROTEIN; CALCIUM ION; MEMBRANE RECEPTOR; N ETHYLMALEIMIDE; NEUROTRANSMITTER;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; EXOCYTOSIS; GIANT AXON; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SQUID; SYNAPSE VESICLE;

ADENOSINE TRIPHOSPHATASES; AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CARRIER PROTEINS; DECAPODIFORMES; EXCITATORY POSTSYNAPTIC POTENTIALS; EXOCYTOSIS; GLUTAMIC ACID; KINETICS; MEMBRANE FUSION; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; N-ETHYLMALEIMIDE-SENSITIVE PROTEINS; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PRESYNAPTIC TERMINALS; SOLUBLE N-ETHYLMALEIMIDE-SENSITIVE FACTOR ATTACHMENT PROTEINS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; VESICULAR TRANSPORT PROTEINS;

ANIMALIA; CEPHALOPODA;

EID: 0032549091     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.279.5354.1203     Document Type: Article

References (53)

1. G. J. Augustine, M. P. Charlton, S. J. Smith, Annu. Rev. Neurosci. 10, 633 (1987); J. H. Byrne and E. R. Kandel, J. Neurosci. 16, 425 (1996); P. De Camilli, S. D. Emr, P. S. McPherson, P. Novick, Science 271, 1533 (1996).
2. G. J. Augustine, M. P. Charlton, S. J. Smith, Annu. Rev. Neurosci. 10, 633 (1987); J. H. Byrne and E. R. Kandel, J. Neurosci. 16, 425 (1996); P. De Camilli, S. D. Emr, P. S. McPherson, P. Novick, Science 271, 1533 (1996).
3. G. J. Augustine, M. P. Charlton, S. J. Smith, Annu. Rev. Neurosci. 10, 633 (1987); J. H. Byrne and E. R. Kandel, J. Neurosci. 16, 425 (1996); P. De Camilli, S. D. Emr, P. S. McPherson, P. Novick, Science 271, 1533 (1996).
4. H. Parnas and I. Parnas, J. Membr. Biol. 142, 267 (1994).
5. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); R. H. Scheller, Neuron 14, 893 (1995); G. J. Augustine, M. E. Burns, W. M. DeBello, D. L. Pettit, F. E. Schweizer, Annu. Rev. Pharmacol. Toxicol. 36, 659 (1996).
6. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); R. H. Scheller, Neuron 14, 893 (1995); G. J. Augustine, M. E. Burns, W. M. DeBello, D. L. Pettit, F. E. Schweizer, Annu. Rev. Pharmacol. Toxicol. 36, 659 (1996).
7. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); R. H. Scheller, Neuron 14, 893 (1995); G. J. Augustine, M. E. Burns, W. M. DeBello, D. L. Pettit, F. E. Schweizer, Annu. Rev. Pharmacol. Toxicol. 36, 659 (1996).
8. J. E. Rothman, Nature 372, 55 (1994); T. C. Südhof, ibid. 375, 645 (1995); R. H. Scheller, Neuron 14, 893 (1995); G. J. Augustine, M. E. Burns, W. M. DeBello, D. L. Pettit, F. E. Schweizer, Annu. Rev. Pharmacol. Toxicol. 36, 659 (1996).
9. S. W. Whiteheart et al., J. Cell Biol. 126, 945 (1994).
10. M. I. Colombo, M. Taddese, S. W. Whiteheart, P. D. Stahl, J. Biol. Chem. 271, 18810 (1996); E. E. Nagiec, A. Bernstein, S. W. Whiteheart, ibid. 270, 29182 (1995).
11. M. I. Colombo, M. Taddese, S. W. Whiteheart, P. D. Stahl, J. Biol. Chem. 271, 18810 (1996); E. E. Nagiec, A. Bernstein, S. W. Whiteheart, ibid. 270, 29182 (1995).
12. J. Z. Young, Philos. Trans. R. Soc. London Ser. B 229, 465 (1939).
13. 2-terminal amino acids (Gen-Bank accession number Y16416).
14. K. Bommert et al., Nature 363, 163 (1993).
15. 2-terminus and amidated at the COOH-terminus) were synthesized by Biosynthesis (Lewisville, TX), Chiron Mimotopes (Sidney, Australia), and the Protein Core Facility of the University of Texas Health Science Center (San Antonio, TX).
16. L. Pallanck, R. W. Ordway, B. Ganetzky, Nature 376, 25 (1995).
17. O. Siddiqi and S. Benzer, Proc. Natl. Acad. Sci. U.S.A. 73, 3253 (1976). Although this previous study shows that transmission is impaired in the comatose mutant, it does not demonstrate a requirement for NSF in transmitter release; the comatose mutation could block transmission through a variety of mechanisms, such as by reducing axonal excitability or postsynaptic receptor sensitivity.
18. T. Söllner et al., Nature 362, 318 (1993); T. Söllner, M. K. Bennett, S. W. Whiteheart, R. H. Scheller, J. E. Rothman, Cell 75, 409 (1993).
19. T. Söllner et al., Nature 362, 318 (1993); T. Söllner, M. K. Bennett, S. W. Whiteheart, R. H. Scheller, J. E. Rothman, Cell 75, 409 (1993).
20. A. Morgan, R. Dimaline, R. D. Burgoyne, J. Biol. Chem. 269, 29347 (1994); R. J. O. Barnard, A. Morgan, R. D. Burgoyne, J. Cell Biol. 139, 875 (1997).
21. A. Morgan, R. Dimaline, R. D. Burgoyne, J. Biol. Chem. 269, 29347 (1994); R. J. O. Barnard, A. Morgan, R. D. Burgoyne, J. Cell Biol. 139, 875 (1997).
22. 2, and 0.6 mM ATP. After incubation for 45 min at 37°C, released phosphate was quantified with a colorimetric assay, and SNAP-stimulated ATPase activity was calculated by subtracting values obtained from parallel incubations containing no immobilized SNAP.
23. For testing postsynaptic responsiveness to glutamate, 100 μM caged glutamate [N-(α-carboxy-2-nitrobenzyl)-L-glutamic acid] (Molecular Probes) was added to the bath solution. Flashes of ultraviolet light were delivered through a 20x water immersion lens (numerical aperture, 0.5) (Olympus) with a capacitor discharge flash lamp (Cairn Research, Faversham, UK) [J. E. Corrie et al., J. Physiol. (London) 465, 1 (1993); R. Wieboldt et al., Proc. Natl. Acad. Sci. U.S.A. 91, 8752 (1994)].
24. For testing postsynaptic responsiveness to glutamate, 100 μM caged glutamate [N-(α-carboxy-2-nitrobenzyl)-L-glutamic acid] (Molecular Probes) was added to the bath solution. Flashes of ultraviolet light were delivered through a 20x water immersion lens (numerical aperture, 0.5) (Olympus) with a capacitor discharge flash lamp (Cairn Research, Faversham, UK) [J. E. Corrie et al., J. Physiol. (London) 465, 1 (1993); R. Wieboldt et al., Proc. Natl. Acad. Sci. U.S.A. 91, 8752 (1994)].
25. Differences in the time courses of peptide disruption of release kinetics and EPSC amplitude evident in Fig. 4A were not observed in all experiments, so it is unclear whether these two physiological actions arose from one or more molecular perturbations.
26. L-trans-Pyrrolidine-2,4-dicarbocylic acid (0.5 to 1 mM) and D,L-threo-β-hydroxyaspartic acid (300 to 600 μM) were tested in combination at 16° to 20°C [J. S. Isaacson and R. A. Nicoll, J. Neurophysiol. 70, 2187 (1993); G. Tong and C. E. Jahr, Neuron 13, 1195 (1994); J. S. Diamond and C. E. Jahr, J. Neurosci. 17, 4672 (1997)].
27. L-trans-Pyrrolidine-2,4-dicarbocylic acid (0.5 to 1 mM) and D,L-threo-β-hydroxyaspartic acid (300 to 600 μM) were tested in combination at 16° to 20°C [J. S. Isaacson and R. A. Nicoll, J. Neurophysiol. 70, 2187 (1993); G. Tong and C. E. Jahr, Neuron 13, 1195 (1994); J. S. Diamond and C. E. Jahr, J. Neurosci. 17, 4672 (1997)].
28. L-trans-Pyrrolidine-2,4-dicarbocylic acid (0.5 to 1 mM) and D,L-threo-β-hydroxyaspartic acid (300 to 600 μM) were tested in combination at 16° to 20°C [J. S. Isaacson and R. A. Nicoll, J. Neurophysiol. 70, 2187 (1993); G. Tong and C. E. Jahr, Neuron 13, 1195 (1994); J. S. Diamond and C. E. Jahr, J. Neurosci. 17, 4672 (1997)].
29. S. D. Hess, P. A. Doroshenko, G. J. Augustine, Science 259, 1169 (1993); J. M. Hunt et al., Neuron 12, 1269 (1994).
30. S. D. Hess, P. A. Doroshenko, G. J. Augustine, Science 259, 1169 (1993); J. M. Hunt et al., Neuron 12, 1269 (1994).
31. W. M. DeBello et al., Nature 373, 626 (1995).
32. V. O'Connor et al., Proc. Natl. Acad. Sci. U.S.A. 94, 12186 (1997).
33. 2+ entry.
34. I. Bezprozvanny, R. H. Scheller, R. W. Tsien, Nature 378, 623 (1995); O. Wiser, M. K. Bennett, D. Atlas, EMBO J. 15, 4100 (1996).
35. I. Bezprozvanny, R. H. Scheller, R. W. Tsien, Nature 378, 623 (1995); O. Wiser, M. K. Bennett, D. Atlas, EMBO J. 15, 4100 (1996).
36. T. F. Martin et al., Cold Spring Harbor Symp. Quant. Biol. 60, 197 (1995).
37. A. Mayer, W. Wickner, A. Haas, Cell 85, 83 (1996); B. J. Nichols, C. Ungermann, H. R. Pelham, W, T. Wickner, A. Haas, Nature 387, 199 (1997).
38. A. Mayer, W. Wickner, A. Haas, Cell 85, 83 (1996); B. J. Nichols, C. Ungermann, H. R. Pelham, W, T. Wickner, A. Haas, Nature 387, 199 (1997).
39. D. Fasshauer, H. Otto, W. K. Eliason, R. Jahn, A. T. Brünger, J. Biol. Chem. 272, 28036 (1997).
40. These experiments were performed at 6° to 10°C to reduce the rate of spontaneous transmitter release. No use dependence was observed at 15°C, presumably because of the high rate of spontaneous transmitter release at this temperature [D. W. Mann and R. W. Joyner, J. Neurobiol. 9, 329 (1978)]. At 6° to 10°C, use dependence was observed in 11 of 12 experiments.
41. P. I. Hanson, H. Otto, N. Barton, R. Jahn, J. Biol. Chem. 270, 16955 (1995); P. I. Hanson, R. Roth, H. Morisaki, R. Jahn, J. E. Heuser, Cell 90, 523 (1997); L. L. Pellegrini, V. O'Connor, F. Lottspeich, H. Betz, EMBO J. 14, 4705 (1995).
42. P. I. Hanson, H. Otto, N. Barton, R. Jahn, J. Biol. Chem. 270, 16955 (1995); P. I. Hanson, R. Roth, H. Morisaki, R. Jahn, J. E. Heuser, Cell 90, 523 (1997); L. L. Pellegrini, V. O'Connor, F. Lottspeich, H. Betz, EMBO J. 14, 4705 (1995).
43. P. I. Hanson, H. Otto, N. Barton, R. Jahn, J. Biol. Chem. 270, 16955 (1995); P. I. Hanson, R. Roth, H. Morisaki, R. Jahn, J. E. Heuser, Cell 90, 523 (1997); L. L. Pellegrini, V. O'Connor, F. Lottspeich, H. Betz, EMBO J. 14, 4705 (1995).
44. V. O'Connor et al., Biochem. Soc. Trans. 24, 666 (1996); J. E. Rothman and T. H. Söllner, Science 276, 1212 (1997).
45. V. O'Connor et al., Biochem. Soc. Trans. 24, 666 (1996); J. E. Rothman and T. H. Söllner, Science 276, 1212 (1997).
46. T. D. Parsons, J. R. Coorssen, H. Horstmann, W. Almers, Neuron 15, 1085 (1995); A. Banerjee, V. A. Barry, B. R. DasGupta, T. F. J. Martin, J. Biol. Chem. 271, 20223 (1996).
47. T. D. Parsons, J. R. Coorssen, H. Horstmann, W. Almers, Neuron 15, 1085 (1995); A. Banerjee, V. A. Barry, B. R. DasGupta, T. F. J. Martin, J. Biol. Chem. 271, 20223 (1996).
48. Although NSF has been proposed to act before docking in yeast vacuolar fusion (24), it is possible that the "predocking" reaction monitored in such in vitro studies is equivalent to the priming observed here and elsewhere (23, 29). For example, docking of synaptic vesicles might lead to a biochemically labile vesicle-membrane interaction that is consolidated during subsequent NSF-regulated priming.
49. R. Rahamimoff and J. M. Fernandez, Neuron 18,17 (1997).
50. B. Katz and R. Miledi, Proc. R. Soc. London Ser. B 161, 483 (1965).
51. S. S. Vogel, P. S. Blank, J. Zimmerberg, J. Cell Biol. 134, 329 (1996).
52. A. Vyshedskiy and J.-W. Lin, J. Neurophysiol. 78, 1791 (1997).
53. We thank L. Hawkey and S. Huber for electron microscopy, S. Hilfiker for help with uptake blocker experiments, M. Thomas for use of a flash lamp, A. Niehuis for technical assistance, J. Battey for the squid cDNA library, J. E. Rothman for expression vectors for α-SNAP and NSF, A. Makusky and L. Bonewald for peptide synthesis, and T. Blanpied for critical reading of the manuscript. Supported by grants from NIH, Deutsche Forschungsgemeinschaft, Verband der Chemischen Industrie, and the Human Frontier Science Program.